Monograph
R03AK07 - Formoterol and Budesonide |
Not porphyrinogenic |
NP |
Rationale
Probably insignificant metabolic load of two safe substances.
Chemical description
Inhalation powder used in asthma containing the glucocorticosteroide budesonide Glucocorticoide with strong antiinflammatory effect used in nasal spray in allergic and vasomotor rhinitis. The amount of budesonide in each dose is 160 µg. Systemic exposure 33%. and the bronchodilating formotherolfumarate dihydrate, adrenergic selective beta-2-stimulator with long durationof effect. About 90% of the dose (4,5µg), may be swallowed and absorbed. Plasma cancentrations are below the detection limit. Eliminated after direct glucuronidation and 0-demetylation followed by glucuronidation. glucocorticoides: EPI-list: safe French list: authorized South African list: use Kalman, Bonkowski: safe The Merck Manual: safe Tschudy DP, Lamon JM: safe Moore MR, Hift RJ: safe French list: authorized South African list: use
IPNet drug reports
Uneventful use reported in 15 patients with acute porphyria.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Belgium
United Kingdom
Denmark
Norway
Poland
Luxembourg
Iceland
Finland
Latvia
Serbia
